Reuters logo
BRIEF-Neos Therapeutics reports Q1 loss per share of $0.87
May 9, 2017 / 11:33 AM / 7 months ago

BRIEF-Neos Therapeutics reports Q1 loss per share of $0.87

May 9 (Reuters) - Neos Therapeutics Inc

* Neos Therapeutics reports first quarter 2017 financial results

* Qtrly net loss per share of common stock, basic and diluted $0.87

* Q2 earnings per share view $-0.87, revenue view $6.0 million -- Thomson Reuters I/B/E/S

* Qtrly net product sales $5.6 million versus $2.6 million Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below